The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
The Role of the C-terminal Domain of Human Collagenase-3 (MMP-13) in the Activation of Procollagenase-3, Substrate Specificity, and Tissue Inhibitor of Metalloproteinase Interaction
Open accessAbstract
Recombinant human procollagenase-3 and a C-terminal truncated form (Delta249-451 procollagenase-3) have been stably expressed in myeloma cells and purified. The truncated proenzyme could be processed by aminophenylmercuric acetate via a short-lived intermediate form (N-terminal Leu58) to the final active form (N-terminal Tyr85). The kinetics of activation were not affected by removal of the hemopexin-like C-terminal domain. The specific activities of both collagenase-3 and Delta249-451 collagenase-3 were found to be similar using two quenched fluorescent substrates, but Delta249-451 collagenase-3 failed to cleave native triple helical collagens (types I and II) into characteristic one- and three-quarter fragments. It was noted, however, that the beta1,2(I) chains of type I collagen were susceptible to Delta249-451 collagenase-3, which indicates that the catalytic domain displays telopeptidase activity, thereby generating alpha1,2(I) chains that are slightly shorter than those in native type I collagen. It can be concluded that the C-terminal domain is only essential for the triple helicase activity of collagenase-3. Binding of procollagenase-3 and active collagenase-3 to type I collagen is mediated by the C-terminal domain. Both collagenase-3 and Delta249-451 collagenase-3 hydrolyzed the large tenascin C isoform, fibronectin, recombinant fibronectin fragments, and type IV, IX, X, and XIV collagens; thus, these events were independent from C-terminal domain interactions. In contrast, the minor cartilage type XI collagen was resistant to cleavage. Kinetic analysis of the mechanism of inhibition of wild-type and Delta249-451 collagenase-3 by wild-type and mutant tissue inhibitors of metalloproteinase (TIMPs) revealed that the association rates for complex formation were influenced by both N- and C-terminal domain interactions. The C-terminal domain of wild-type collagenase-3 promoted increased association rates with the full-length inhibitors TIMP-1 and TIMP-3 and the hybrid N.TIMP-2/C.TIMP-1 by a factor of up to 33. In contrast, the association rates for complex formation with TIMP-2 and N.TIMP-1/C.TIMP-2 were only marginally affected by C-terminal domain interactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitchell, P. G., Magna, H. A., Reeves, L. M., Lopresti-Morrow, L. L., Yocum, S. A., Rosner, P. J., Geoghegan, K. F., & Hambor, J. E. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118475 · Cited by 940
Biochemical Characterization of Human Collagenase-3
Knäuper, V., López-Otin, C., Smith, B., Knight, G., & Murphy, G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.3.1544 · Cited by 881
Self-citationFreije, J. M., Díez-Itza, I., Balbín, M., Sánchez, L. M., Blasco, R., Tolivia, J., & López-Otín, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)89457-7 · Cited by 762
Cellular Mechanisms for Human Procollagenase-3 (MMP-13) Activation
Knäuper, V., Will, H., López-Otin, C., Smith, B., Atkinson, S. J., Stanton, H., Hembry, R. M., & Murphy, G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17124 · Cited by 747
Self-citationA novel coumarin‐labelled peptide for sensitive continuous assays of the matrix metalloproteinases
Knight, C. G., Willenbrock, F., & Murphy, G. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80300-6 · Cited by 702
Self-citationGoldberg, G. I., Wilhelm, S. M., Kronberger, A., Bauer, E. A., Grant, G. A., & Eisen, A. Z. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84605-7 · Cited by 632
Will, H., Atkinson, S. J., Butler, G. S., Smith, B., & Murphy, G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17119 · Cited by 569
Self-citationComparison of human stromelysin and collagenase by cloning and sequence analysis
Whitham, S. E., Murphy, G., Angel, P., Rahmsdorf, H. J., Smith, B. J., Lyons, A., Harris, T. J. R., Reynolds, J. J., Herrlich, P., & Docherty, A. J. P. (1986) · Biochemical Journal · doi:10.1042/bj2400913 · Cited by 436
Self-citationMechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin)
Suzuki, K., Enghild, J. J., Morodomi, T., Salvesen, G., & Nagase, H. (1990) · Biochemistry · doi:10.1021/bi00496a016 · Cited by 431
Hasty, K. A., Pourmotabbed, T. F., Goldberg, G. I., Thompson, J. P., Spinella, D. G., Stevens, R. M., & Mainardi, C. L. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38413-3 · Cited by 401
Cited by
Visse, R., & Nagase, H. (2003) · Circulation Research · doi:10.1161/01.res.0000070112.80711.3d · Cited by 4,575
Regulation of matrix metalloproteinase expression in tumor invasion
Westermarck, J., & Kähäri, V. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.8.781 · Cited by 1,494
Inflammatory and immune pathways in the pathogenesis of periodontal disease
Cekici, A., Kantarci, A., Hasturk, H., & Van Dyke, T. E. (2014) · Periodontology 2000 · doi:10.1111/prd.12002 · Cited by 1,415
“Matrix metalloproteinase-13 (collagenase 3) is expressed by the basal cells of the gingival pocket epithelium (240); it degrades type I, type III and type IV collagens, as well as fibronectin, tenascin and some proteoglycans (105, 120).”
BackgroundMatrix metalloproteinases in tumor invasion and metastasis
Stamenkovic, I. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0379 · Cited by 815
Matrix-Degrading Metalloproteinases in Photoaging
Quan, T., Qin, Z., Xia, W., Shao, Y., Voorhees, J. J., & Fisher, G. J. (2009) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1038/jidsymp.2009.8 · Cited by 740
Collagenase unwinds triple‐helical collagen prior to peptide bond hydrolysis
Chung, L., Dinakarpandian, D., Yoshida, N., Lauer‐Fields, J. L., Fields, G. B., Visse, R., & Nagase, H. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600318 · Cited by 675
Sukhova, G. K., Schönbeck, U., Rabkin, E., Schoen, F. J., Poole, A. R., Billinghurst, R. C., & Libby, P. (1999) · Circulation · doi:10.1161/01.cir.99.19.2503 · Cited by 657
Little, C. B., Barai, A., Burkhardt, D., Smith, S. M., Fosang, A. J., Werb, Z., Shah, M., & Thompson, E. W. (2009) · Arthritis & Rheumatism · doi:10.1002/art.25002 · Cited by 642
Matrix metalloproteinases in skin
Kähäri, V., & Saarialho‐Kere, U. (1997) · Experimental Dermatology · doi:10.1111/j.1600-0625.1997.tb00164.x · Cited by 607
Creemers, E. E. J. M., Cleutjens, J. P. M., Smits, J. F. M., & Daemen, M. J. A. P. (2001) · Circulation Research · doi:10.1161/hh1501.094396 · Cited by 598
Matrix Metalloproteinases as Therapeutic Targets for Idiopathic Pulmonary Fibrosis
Craig, V. J., Zhang, L., Hagood, J. S., & Owen, C. A. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2015-0020tr · Cited by 507
Overall, C. M. (2002) · Molecular Biotechnology · doi:10.1385/mb:22:1:051 · Cited by 504
Mechanisms for pro matrix metalloproteinase activation
MURPHY, G., STANTON, H., COWELL, S., BUTLER, G., KNÄUPER, V., ATKINSON, S., & GAVRILOVIC, J. (1999) · APMIS · doi:10.1111/j.1699-0463.1999.tb01524.x · Cited by 441
Self-citationChondrocyte ferroptosis contribute to the progression of osteoarthritis
Yao, X., Sun, K., Yu, S., Luo, J., Guo, J., Lin, J., Wang, G., Guo, Z., Ye, Y., & Guo, F. (2021) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2020.09.006 · Cited by 421
Kähäri, V.-M., & Saarialho-Kere, U. (1999) · Annals of Medicine · doi:10.3109/07853899909019260 · Cited by 408
Itoh, Y. (2001) · The EMBO Journal · doi:10.1093/emboj/20.17.4782 · Cited by 399
Regulation of matrix metalloproteinase activity in health and disease
Hadler‐Olsen, E., Fadnes, B., Sylte, I., Uhlin‐Hansen, L., & Winberg, J. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07920.x · Cited by 383
Colige, A., Sieron, A. L., Li, S.-W., Schwarze, U., Petty, E., Wertelecki, W., Wilcox, W., Krakow, D., Cohn, D. H., Reardon, W., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302504 · Cited by 370
Akhtar, N., Rasheed, Z., Ramamurthy, S., Anbazhagan, A. N., Voss, F. R., & Haqqi, T. M. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27329 · Cited by 331
Ala-aho, R., & Kähäri, V.-M. (2005) · Biochimie · doi:10.1016/j.biochi.2004.12.009 · Cited by 325
Relating matrix metalloproteinase structure to function: Why the “hemopexin” domain?
Murphy, G., & Knäuper, V. (1997) · Matrix Biology · doi:10.1016/s0945-053x(97)90025-1 · Cited by 306
Self-citationNew insights on the MMP-13 regulatory network in the pathogenesis of early osteoarthritis
Li, H., Wang, D., Yuan, Y., & Min, J. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1454-2 · Cited by 293
Jiménez, M. J. G., Balbín, M., López, J. M., Alvarez, J., Komori, T., & López-Otín, C. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.6.4431 · Cited by 296
Ravanti, L., Heino, J., López-Otı́n, C., & Kähäri, V.-M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.2446 · Cited by 278
Study of matrix metalloproteinases and their inhibitors in breast cancer
Vizoso, F. J., González, L. O., Corte, M. D., Rodríguez, J. C., Vázquez, J., Lamelas, M. L., Junquera, S., Merino, A. M., & García-Muñiz, J. L. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603666 · Cited by 271
Extracellular vesicles in the pathogenesis of rheumatoid arthritis and osteoarthritis
Withrow, J., Murphy, C., Liu, Y., Hunter, M., Fulzele, S., & Hamrick, M. W. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-1178-8 · Cited by 267
Crystal Structure of Human MMP9 in Complex with a Reverse Hydroxamate Inhibitor
Rowsell, S., Hawtin, P., Minshull, C. A., Jepson, H., Brockbank, S. M. V., Barratt, D. G., Slater, A. M., McPheat, W. L., Waterson, D., Henney, A. M., et al. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00262-0 · Cited by 254
Patterns of matrix metalloproteinase and TIMP expression in chronic ulcers
Saarialho-Kere, U. K. (1998) · Archives of Dermatological Research · doi:10.1007/pl00007453 · Cited by 187
Matrix metalloproteinases in destructive lung disease
McGarry Houghton, A. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.02.002 · Cited by 172
Andersen, T. L., del Carmen Ovejero, M., Kirkegaard, T., Lenhard, T., Foged, N. T., & Delaissé, J.-M. (2004) · Bone · doi:10.1016/j.bone.2004.06.019 · Cited by 145
Tam, E. M., Moore, T. R., Butler, G. S., & Overall, C. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407186200 · Cited by 142
Regulation and Function of Matrix Metalloproteinase-13 in Cancer Progression and Metastasis
Li, S., Pritchard, D. M., & Yu, L.-G. (2022) · Cancers · doi:10.3390/cancers14133263 · Cited by 82
Metadata
- Authors
- Knäuper, V., Cowell, S., Smith, B., López-Otin, C., O'Shea, M., Morris, H., Zardi, L., & Murphy, G.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1997-03
- Volume
- 272
- Issue
- 12
- Pages
- 7608-7616
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1992512865
- Cited by
- 350
- References
- 40
- FWCI
- 8.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.